Menu
Offerings
Clubs
Portfolio
Founders
Academy
About Us
Your Window Into the Innovation Economy
Blogs, Webinars and Podcasts covering technology, start-ups, and venture investing
Fund
AV Fundraise
AV: AI First Fund
AV: AI Fund
AV: Anti-Bias Fund
AV: Blockchain, Digital Assets & Marketplaces Fund
AV: CIO Select Fund
AV: Deep Tech
AV: Doctors Innovate Fund
AV: Elite Engineering Fund
AV: Emerging Markets Fund
Foundation Fund
AV: Global Fund
AV: Growth Fund
AV: Health AI
AV: Impact Fund
AV: Opportunity Fund
AV: Post-COVID Fund
AV: Seed Fund
AV: Social Impact Fund
AV: Sports Fund
AV: Total Access Fund
AV: U.S. Strategic Tech Fund
AV: Women's Fund
Brown: Waterman Ventures
BU & BC: Comm Ave Ventures
BYU: Provo Ventures
Carnegie Mellon: The Fence Ventures
Columbia: 116 Street Ventures
Cornell: Triphammer Ventures
Dartmouth: Green D Ventures
Duke: Towerview Ventures
GEF-AV Venture Capital Fund
Georgetown: Potomac Ventures
Georgia Tech: Fowler Street Ventures
Georgia: Arch View Ventures
Harvard: Yard Ventures
MIT: Castor Ventures
Northwestern: Purple Arch Ventures
Notre Dame: Two Lakes Ventures
NYU: Bleecker Street Ventures
Ohio State: Mirror Lake Ventures
Penn State: Allen Street Ventures
Penn: Chestnut Street Ventures
Princeton: Nassau Street Ventures
Purdue: Stadium Avenue Ventures
Stanford: Spike Ventures
Syndications
Texas A&M: Ring Ventures
U Chicago: Lakeshore Ventures
University of Texas: Congress Avenue Ventures
U Washington: Yoshino Ventures
UC Berkeley: Strawberry Creek Ventures
UCLA: Westwood Ventures
UNC: Franklin Street Ventures
University of Michigan: Arbor Street Ventures
USC: Expo Ventures
UVA: Emmet Street Ventures
Wisconsin: Bascom Ventures
Yale: Blue Ivy Ventures
Media type
Article
AVTV
Podcast
Press Release
Tech Optimist
Video
Webinar
Topic
About AV
AV Academy
AVTV - Fascinating Founder Stories
For Founders
Investment Insights and Trends
One Startup to Know
Startup and Founder Stories
VC 101
VC Masterclass
Sort by
Newest first
Oldest first
November 9, 2026
You Don’t Need to Predict the Next Great Startup.
Friends, family, and classmates ask me some version of the same question all the time: “Mike, how should I invest in venture capital?”
by Michael Collins
November 6, 2026
The Preclinical Funding Sweetspot: Chase Your Trifecta+
In The Preclinical Arbitrage, we found a bifurcated market for biotech preclinical companies: most dollars flowing into a small number of huge rounds, and a long tail of companies raising little or nothing at all. We wanted to know why.
by Luca Giani
November 5, 2026
The Buyer Changed: What Actually Happened in Defense Tech, and Where the Money Is Really Going
For 40 years, defense followed a predictable pattern: startups won pilots, and primes won programs of record. That pattern has started to break, and the cause has less to do with technology or politics than with how the Pentagon buys.
by Drew Wandzilak
November 2, 2026
Time Arbitrage: Why Patience Is an Investing Edge
Turn on any screen right now and you’ll be told that you’re behind.
by Michael Collins
November 2, 2026
Today, Everyone’s an Entrepreneur
A few weeks ago, I wrote that most people are not entrepreneurs. I meant it. Most people should never start a company. Now I’m going to tell you something that sounds the exact opposite: Today, everyone’s an entrepreneur.
by Michael Collins
November 2, 2026
When Intelligence Is Free, What Gets Expensive?
The leading AI labs are building systems with the aim of exceeding expert human performance across most cognitive work. Forecasters anticipate that milestone, which is called artificial general intelligence (AGI), could happen within the next two years. As Managing Partner of Alumni Ventures’ Deep Tech Fund, I make investments with a five-to 10-year horizon, so I’m investing for a post-AGI world and thinking about what gets expensive when intelligence is free. Below, I lay out what gets cheap, what gets scarce, and where the Deep Tech Fund is investing as a result.
by Matt Caspari
October 29, 2026
AI Goes Nuclear: Why Software Companies Became Nuclear's Customer, and Where the Value Sits
For two decades, doubting new American nuclear was the right call. What changed is not the technology. It is who is buying.
by Drew Wandzilak
October 22, 2026
AI Is Getting a Body
Robots today have hourly wages, tomorrow they’ll be telling jokes at the water cooler. Here is what is changing, what is working, what isn’t, and where we are investing.
by Michael Beer
October 17, 2026
So You Think You’re an Entrepreneur? (You’re Not)
Wealth, power, control, the sense of accomplishment. Lots of people want the outcomes that come with being a successful entrepreneur. And a steady number set out to do that every day.
by Michael Collins
October 7, 2026
Where Value Accrues In The Modern Revtech Stack
Explore how AI is reshaping the RevTech stack and why Alumni Ventures sees opportunity in decision-making, customer retention, and expansion.
by Glenn Borok
October 7, 2026
Jobs Have Changed Forever (And More Than You Think)
AV CEO Mike Collins shares five ways AI is changing jobs — and why the future of work demands broader skills, better judgment, and an AI-first mindset.
by Michael Collins
October 7, 2026
The Oncology Advantage: Why AI Could Change the Investment Math
Most people’s mental model of cancer is 20 years out of date. The picture is now much more hopeful. The U.S. cancer death rate fell 34% between 1991 and 2023. The 5-year survival rate for all cancers combined is 70%. Yet more than 2.1 million Americans are expected to receive a cancer diagnosis in 2026, and over 600,000 will die from the disease. There is substantial progress, alongside enormous unmet need.[1]
by Luca Giani
1 of 20
Previous
Next